Both in R&D — Physical & Biological Sciences
Incyte Genomics vs NRC Health
Over the past year INCY returned +11.6% and NRC returned +81.1%; their daily moves had a correlation of 0.14.
INCY +11.6% NRC +81.1%Growth of $1, one year, split-adjusted
| Metric | INCY | NRC |
|---|---|---|
| Price | $118.01 | $25.48 |
| Market cap | $24.05B | $540.7M |
| Today | −3.94% | −5.87% |
| 1 month | +4.0% | +26.2% |
| 6 months | +20.7% | +36.0% |
| Year to date | +19.5% | +35.7% |
| 1 year | +14.7% | +84.9% |
| Revenue growth (YoY) | +14.0% | +11.0% |
| Gross margin | 93.0% | 60.0% |
| Net margin | −50.4% | 12.3% |
| P/E (TTM) | 59.6× | 88.2× |
| Price / sales | 4.0× | 3.8× |
| Net cash | $3.82B | -$99.3M |
| Dividend yield | — | 2.51% |
| Volatility (60d) | 29.8% | 51.3% |
| Short % of float | 5.9% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).